The first multiple sclerosis (MS) clinical trial to focus only on people who can't walk is to start recruiting. The ChariotMS trial, led by researchers at Queen Mary University of London, will test whether cladribine tablets ...
Nov 20, 2020
0
0
A survey of U.S. multiple sclerosis, or MS, specialist clinicians reveals the COVID-19 pandemic has created major changes in how they deliver care.
Apr 19, 2021
0
8
Results of a study using several imaging methods showed that CCSVI (chronic cerebrospinal venous insufficiency) occurs at a low rate in both people with multiple sclerosis (MS) and non-MS volunteers, contrary to some previous ...
Mar 7, 2013
0
0
Multiple sclerosis manifests itself in many different ways and different courses. A recent effort to fine-tune descriptions – or phenotypes—of MS was undertaken by an international team of leaders in MS research and clinical ...
Jun 4, 2014
0
0
The past five years have seen significant advancements in diagnosing and treating multiple sclerosis (MS), but challenges remain—especially among patients who are living longer, a result of more effective treatments—according ...
Nov 9, 2023
0
2
The rate of multiple sclerosis (MS) cases varies greatly by race and ethnicity. A new study suggests that the prevalence of MS in Black and white people is similarly high, while much lower in Hispanic and Asian people. The ...
Apr 27, 2022
0
0
